Related references
Note: Only part of the references are listed.Auranofin prevents liver fibrosis by system Xc-mediated inhibition of NLRP3 inflammasome
Hyun Young Kim et al.
COMMUNICATIONS BIOLOGY (2021)
Hepatocyte mitochondria-derived danger signals directly activate hepatic stellate cells and drive progression of liver fibrosis
Ping An et al.
NATURE COMMUNICATIONS (2020)
Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors
Yang Yang et al.
CELL DEATH & DISEASE (2019)
Acetate attenuates inflammasome activation through GPR43-mediated Ca2+-dependent NLRP3 ubiquitination
Mengda Xu et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2019)
The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation
Nathan Kelley et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Role of Caspase 1 in Ischemia/Reperfusion Injury of the Myocardium
Ali Rauf et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2019)
The different expression of caspase-1 in HBV-related liver disease and acts as a biomarker for acute-on-chronic liver failure
Xiangying Zhang et al.
BMC GASTROENTEROLOGY (2019)
Omega-3 fatty acids decrease oxidative stress and inflammation in macrophages from patients with small abdominal aortic aneurysm
Lara T. Meital et al.
SCIENTIFIC REPORTS (2019)
Quantitative Systems Toxicology Analysis of In Vitro Mechanistic Assays Reveals Importance of Bile Acid Accumulation and Mitochondrial Dysfunction in TAK-875-Induced Liver Injury
Diane M. Longo et al.
TOXICOLOGICAL SCIENCES (2019)
NLRP3 Inflammasome and Inflammatory Bowel Disease
Yu Zhen et al.
FRONTIERS IN IMMUNOLOGY (2019)
Fasiglifam (TAK-875), a G Protein-Coupled Receptor 40 (GPR40) Agonist, May Induce Hepatotoxicity through Reactive Oxygen Species Generation in a GPR40-Dependent Manner
Minjeong Kim et al.
BIOMOLECULES & THERAPEUTICS (2018)
Targeting the NLRP3 inflammasome in inflammatory diseases
Matthew S. J. Mangan et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
GPCRs in NLRP3 Inflammasome Activation, Regulation, and Therapeutics
Tiantian Tang et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2018)
NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice
Auvro R. Mridha et al.
JOURNAL OF HEPATOLOGY (2017)
Molecular mechanisms regulating NLRP3 inflammasome activation
Eun-Kyeong Jo et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2016)
Pyroptosis as a Regulated Form of Necrosis PI+/Annexin V-/High Caspase 1/Low Caspase 9 Activity in Cells = Pyroptosis?
Jun-ichi Abe et al.
CIRCULATION RESEARCH (2016)
Pyroptosis
Lieselotte Vande Walle et al.
CURRENT BIOLOGY (2016)
Long-term safety and efficacy of fasiglifam (TAK-875), a G-protein-coupled receptor 40 agonist, as monotherapy and combination therapy in Japanese patients with type 2 diabetes: a 52-week open-label phase III study
K. Kaku et al.
DIABETES OBESITY & METABOLISM (2016)
Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores
Xing Liu et al.
NATURE (2016)
Mechanism and Regulation of NLRP3 Inflammasome Activation
Yuan He et al.
TRENDS IN BIOCHEMICAL SCIENCES (2016)
Potentiation of Glucose-stimulated Insulin Secretion by the GPR40-PLC-TRPC Pathway in Pancreatic β-Cells
Hodaka Yamada et al.
SCIENTIFIC REPORTS (2016)
Efficacy and safety of fasiglifam (TAK-875), a G protein-coupled receptor 40 agonist, in Japanese patients with type 2 diabetes inadequately controlled by diet and exercise: a randomized, double-blind, placebo-controlled, phase III trial
K. Kaku et al.
DIABETES OBESITY & METABOLISM (2015)
K+ Efflux Agonists Induce NLRP3 Inflammasome Activation Independently of Ca2+ Signaling
Michael A. Katsnelson et al.
JOURNAL OF IMMUNOLOGY (2015)
Ca2+ Signaling but Not Store-Operated Ca2+ Entry Is Required for the Function of Macrophages and Dendritic Cells
Martin Vaeth et al.
JOURNAL OF IMMUNOLOGY (2015)
GPR40 (FFAR1) - Combined Gs and Gq signaling in vitro is associated with robust incretin secretagogue action ex vivo and in vivo
Maria Hauge et al.
MOLECULAR METABOLISM (2015)
Activation of N-methyl-D-aspartate receptor downregulates inflammasome activity and liver inflammation via a β-arrestin-2 pathway
Ahmad Farooq et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2014)
Activation of GPR40 attenuates chronic inflammation induced impact on pancreatic β-cells health and function
Mahesh Kumar Verma et al.
BMC CELL BIOLOGY (2014)
NLRP3 Inflammasome Activation Results in Hepatocyte Pyroptosis, Liver Inflammation, and Fibrosis in Mice
Alexander Wree et al.
HEPATOLOGY (2014)
Biomarkers of liver cell death
Akiko Eguchi et al.
JOURNAL OF HEPATOLOGY (2014)
Imaging intraorganellar Ca2+ at subcellular resolution using CEPIA
Junji Suzuki et al.
NATURE COMMUNICATIONS (2014)
Ca2+/H+ exchange, lumenal Ca2+ release and Ca2+/ATP coupling ratios in the sarcoplasmic reticulum ATPase
Giuseppe Inesi et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2014)
Inflammasome biology in fibrogenesis
Xinshou Ouyang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
Activation of GPR40 as a Therapeutic Target for the Treatment of Type 2 Diabetes
Charles F. Burant
DIABETES CARE (2013)
Modulating GPR40: therapeutic promise and potential in diabetes
Vincent Poitout et al.
DRUG DISCOVERY TODAY (2013)
Omega-3 Fatty Acids Prevent Inflammation and Metabolic Disorder through Inhibition of NLRP3 Inflammasome Activation
Yiqing Yan et al.
IMMUNITY (2013)
Mechanisms of disease: inflammasome activation and the development of type 2 diabetes
Ryan W. Grant et al.
FRONTIERS IN IMMUNOLOGY (2013)
GPR40: A therapeutic target for mediating insulin secretion (Review)
Xiao-Tao Feng et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2012)
IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice
Jan Petrasek et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
The NLRP3 Inflammasome: A Sensor for Metabolic Danger?
Kate Schroder et al.
SCIENCE (2010)
Gpr40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretion
Sara Edfalk et al.
DIABETES (2008)
Share Paper
